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Abstract 
Background: Monitoring and evaluation of malaria programmes may require a combination of approaches to 
detect any effects of control. This is particularly true at lower transmission levels where detecting both infection and 
exposure to infection will provide additional evidence of any change. This paper describes use of three transmission 
metrics to explore the malaria epidemiology in the highlands of western Kenya.
Methods: A malariometric survey was conducted in June 2009 in two highland districts, Kisii and Rachuonyo South, 
Nyanza Province, Kenya using a cluster design. Enumeration areas were used to sample 46 clusters from which 12 
compounds were randomly sampled. Individuals provided a finger-blood sample to assess malaria infection (rapid 
diagnostic test, PCR) and exposure (anti-Plasmodium falciparum MSP-1 antibodies) and a questionnaire was adminis-
tered to record household factors and assess use of vector control interventions.
Results: Malaria prevalence infection rates were 3.0 % (95 % CI 2.2–4.2 %) by rapid diagnostic test (RDT) and 8.5 % 
(95 % CI 7.0–10.4 %) by PCR and these ranged from 0–13.1 to 0–14.8 % between clusters for RDT and PCR, respec-
tively. Seroprevalence was 36.8 % (95 % CI 33.9–39.8) ranging from 18.6 to 65.8 %. Both RDT and PCR prevalences 
were highest in children aged 5–10 years but the proportion of infections that were sub-patent was highest in those 
between 15 and 20 years of age (78.1 %, 95 % CI 63.0–93.3 %) and those greater than 20 years (73.3 %, 95 % CI 64.5–
81.9 %). Those reporting both indoor residual spraying (IRS) in their home and use of bed nets had lower exposure to 
malaria compared to those who reported using IRS or bed nets alone.
Conclusions: In this highland site in western Kenya malaria transmission was low, but highly heterogeneous. To 
accurately characterize the true extent of malaria transmission, more sensitive and complementary metrics such as 
PCR or serology are required in addition to the standard microscopy and/or RDTs that are routinely used. This is likely 
to be the case in other low endemicity settings.
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Background
In recent years, much attention has been given to the 
debate as to whether malaria elimination is a viable and 
realistic option for malaria-endemic countries [1–3], 
whether the tools currently available are able to achieve 
elimination, and if elimination is a sensible strategy 
for control programmes [1]. What is clear is that met-
rics suited to lower transmission levels will be needed 
to allow accurate evaluation of control and elimination 
programmes [4]. The performance of different metrics 
needs to be characterized in a variety of medium and low 
transmission settings to ensure that the heterogeneity of 
malaria burden can be accurately described, targeted and 
monitored across operationally appropriate geographical 
scales.
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Microscopy has been the historic mainstay of the esti-
mation of infection prevalence. More recently infection 
prevalence has been assessed by rapid diagnostic tests 
(RDT). Both approaches have a similar sensitivity with 
limits of detection in the order of 5–50 parasites/μl [4]. 
Whilst the operational utility of these measures, par-
ticularly RDT, cannot be discounted, sufficient data have 
accumulated to suggest that they significantly under-
estimate the level of infection [5–7]. Molecular meth-
ods based on PCR of DNA detect 0.5–5 parasites/μl 
and reports suggest on average twofold more infections 
than that detected by microscopy [6, 8]. This difference 
is more pronounced in older individuals and in lower 
transmission settings and appears to be related in part 
to immunity and parasite density [5, 9]. The relevance of 
these low-density, sub-patent infections is that they can 
still infect mosquitoes. Furthermore, despite the typi-
cally lower density parasitaemia, the chronic and wide-
spread nature of these infections suggests longer periods 
of infectivity, which therefore act as an important source 
of transmission especially in areas of high vector compe-
tence [5, 10].
In low transmission settings, the burden of malaria 
shifts with infections distributed across age groups. 
There have been few studies comparing the utility of dif-
ferent diagnostics in these settings [6–8, 11, 12]. There is 
increasing evidence that serological measures of expo-
sure (i.e., the detection of antibody responses specific for 
malaria parasites) can provide an additional, more sensi-
tive measure of transmission in these low-endemic areas. 
Antibody responses measured as simple prevalence in 
Somaliland showed that almost one-fifth of people had 
serological evidence of exposure despite the absence of 
parasites by microscopy and that exposure as determined 
by antibody levels was associated with travel to nearby 
Ethiopia [13]. At larger scales, the seroconversion rate 
(SCR) calculated from age and antibody prevalence has 
been shown to correlate with other measures of trans-
mission intensity and therefore may be more useful in 
low-endemic settings [4, 14].
To further understand malaria dynamics in a low trans-
mission setting, a cross-sectional survey was carried 
out in a highland fringe area of western Kenya (altitude 
1400–1600  m). Whilst several studies have reported 
malaria transmission from either lowland or highland 
areas of Nyanza Province [15–20], few have been carried 
out between these two extremes. The aims of the surveys 
were to (1) characterize the epidemiology of Plasmodium 
falciparum in this setting; (2) to assess the utility of dif-
ferent diagnostic tools, including RDTs, PCR, and the 
presence of antibodies to the parasite antigen MSP1-19; 
and, (3) to identify factors associated with malaria infec-
tions/exposures based on the three malaria metrics used.
Methods
Study site and survey procedure
Malaria surveys were conducted in the neighbour-
ing highland districts of Kisii Central, Kisii South and 
Rachuonyo South, Nyanza Province, western Kenya as 
part of the Malaria Transmission Consortium project 
[21]. The total population of the study districts at the 
time of the 2009 national census was 863,000. The area 
is predominantly rural with subsistence agriculture being 
the main occupation. People of the Kisii and Luo eth-
nic group predominantly occupy Kisii Central and Kisii 
South (henceforth referred to as Kisii) and Rachuonyo, 
respectively. Malaria transmission is seasonal with two 
peaks following the bimodal rainfall pattern, the heavi-
est rainfall typically occurring between March and June, 
with a smaller peak in October/November each year. The 
main malaria vectors are Anopheles funestus and Anoph-
eles arabiensis, and P. falciparum is the predominant 
malaria parasite.
Sample size was calculated to adequately define the 
prevalence of P. falciparum infection among differ-
ent age groups with 95  % confidence, with 80  % power, 
and assuming a design effect of 2. Based on histori-
cal prevalence data for the field area and its vicinity, the 
prevalence of infection was assumed to be 15  % among 
children under 5  years of age (the smallest population 
age group being considered in this study). Assuming an 
average household size of six persons and a 15  % non-
response rate, a total sample of 1273 people per district 
was required to in order to estimate age-specific preva-
lence to a precision of ±3 %.
Survey compounds (which represent a family home-
stead of one or more houses) were selected using a two-
stage sampling design. At the first stage, 46 enumeration 
areas (EAs, the primary sampling unit) were selected 
randomly from a sampling frame restricted to EAs with a 
mean altitude of 1400–1600 m (Fig. 1). EAs were defined 
by the Kenya National Bureau of Statistics during the 
2009 national census to demarcate areas with approxi-
mately 500 residents. Urban EAs and EAs with bounda-
ries contiguous with the main Rachuonyo-Kisii boundary 
were excluded.
All compounds in selected EAs were geolocated and 
enumerated. Second stage sampling involved randomly 
selecting 12 compounds. All consenting occupants of 
the compound over the age of 6 months were eligible for 
inclusion in the study.
The survey was conducted in July 2009, at the end 
of the long rainy season. At each of the households, 
informed written consent was sought. The head of house-
hold was interviewed to assess household wealth indices 
and structure and individuals were questioned about 
malaria control behaviours. A finger-prick blood sample 
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was taken from all consenting household members above 
the age of 6 months to measure parasite prevalence using 
PfHRP2 RDT (Paracheck Pf®, Orchid Biomedical Sys-
tems, Goa, India) and haemoglobin levels (HemoCue®, 
Angelholm, Sweden). Blood was also spotted onto fil-
ter paper (3MM Whatman®, Maidstone, UK) for sub-
sequent molecular and serological analysis. Individuals 
with a positive RDT result were treated for malaria at the 
home according to national guidelines with artemether-
lumefantrine (Coartem®, Novartis) or referred to a health 
facility if suspected to be pregnant or allergic to Coar-
tem®. Participants found to be anaemic were provided 
haematinics according to national guidelines at the time 
of the survey.
Ethics, consent and permissions
This study was approved by the ethical committees of 
the London School of Hygiene and Tropical Medicine 
and the Kenya Medical Research Institute (#SSC 1802). 
Approval was also provided by the Division of Malaria 
Control, Ministry of Public Health and Sanitation. 
Prior to the surveys, meetings were held with all dis-
trict administrative representatives, chiefs and district 
health teams to inform them of the study and acquire 
local approval. Community meetings were held at each 
of the EAs to explain the methods of study to potential 
participants. Household heads were approached and 
the study explained to members of the home. Individual 
informed consent was sought from all residents of the 
compound above the age of 6  months by signature or 
thumbprint accompanied by the signature of an inde-
pendent witness. Consent for children under the age 
of 18 was provided by a parent/guardian and children 
between 14 and 17 years also provided written assent by 
signature or thumbprint accompanied by the signature of 
an independent witness. As defined in the Kenya national 
guidelines, participants below 18 years of age who were 
pregnant, married, or a parent were considered ‘mature 
minors’ and consented for themselves [22].
Laboratory procedures: ELISA
Antibody responses to P. falciparum were assessed by 
ELISA as previously described [23]. Briefly, recombinant 
protein P. falciparum MSP-119 was coated on plates at a 
concentration of 0.5  µg/mL in coating buffer and incu-
bated at 4  °C overnight. After blocking with 1  % (w/v) 
skimmed milk solution, the plates were washed, and sam-
ples were added in duplicate at a final dilution of 1:1000, 
with a pool of hyper immune serum titrated on each plate. 
Plates were incubated overnight at 4 °C and 50 µl of HRP-
conjugated rabbit anti Human IgG (DAKO, #P0214) were 
added into each well and incubated. After a further series 
Fig. 1 Map highlighting the location of the randomly selected enumeration areas included in the survey
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of washes, substrate solution (OPD, Sigma #P8287, in 
PBS) was added and the reaction was allowed to develop 
for 15–20 min before addition of stopping solution (2 M 
H2SO4). Raw optical density (OD) measurements were 
averaged and normalized against the positive control 
samples on each plate. The cut-off value of these assays 
to define seropositivity was determined using a mixture 
model, which considers those individuals with OD val-
ues greater than the cut-off determined by the model as 
being seropositive. Age adjusted SCR were calculated by 
fitting a simple reversible catalytic model using the sero-
positivity data to determine the rate at which individuals 
convert from seronegative to seropositive by year of age. 
The seroreversion rate (SRR) was fixed at a reversion rate 
of 4.057 for both population and cluster specific calcula-
tions. The SRR used was obtained according to estimates 
from previous studies, and was fixed to ensure robust esti-
mates of SCR, particularly with the smaller sample sizes 
for the cluster-level estimates [14, 23, 24].
Laboratory procedures: PCR
The presence of a current P. falciparum infection was 
assessed using nested PCR (nPCR). Blood-spotted fil-
ter papers were punched with a sterile hole punch and 
DNA was extracted using a Chelex-saponin method 
as described previously [25]. In brief, filter papers were 
incubated in a 0.5 % saponin-PBS solution overnight. Fil-
ter paper spots were washed once in a 1× PBS solution 
and DNA was eluted by boiling samples in a 6 % Chelex 
DNA/RNAase free solution. Extracted DNA was then 
added to two separate nPCR reactions targeting the ribo-
somal 18S [26] and a modified version targeting mito-
chondrial Cytochrome B region [27]. Gel electrophoresis 
was performed and samples were visualized on an ethid-
ium bromide stained 2 % agarose gel. Samples were con-
sidered to be positive if they were positive in either assay.
Statistical analysis
All statistical analysis was conducted in STATA (v 12.0, 
StataCorps, Texas, USA) using the survey (svy) command 
to account for the two-stage sampling design (EA and com-
pound) and stratifying by district. Prevalence and means 
and the corresponding exact 95 % confidence interval (CI) 
were calculated assuming a binomial and normal distribu-
tion, respectively. Tests of significance were assessed using 
the Spearman’s and Chi square test as appropriate. Socio-
economic status (SES) was generated using a principal 
component analysis (PCA) using household level wealth 
indicators collected as part of the questionnaire [28]. Indi-
cators included education level attained by the head of 
household, house construction including wall, floor and 
roof type, as well as ownership of items such as animals, 
televisions, mobile phones, vehicles, and bicycles. To assess 
the association between the three outcome measures in 
this study, RDT, PCR and seroprevalence, logistic regres-
sion was conducting using the svy command as described 
above. Univariate analysis was conducted to determine the 
association with all potential risk factors. Next, a multi-
variable analysis was conducted in a backwards step-wise 
fashion retaining all variables significant at the 0.05 level. 
Variables included in the analysis were anaemia status (hae-
moglobin <11 g/dl), recent travel, the type of eaves present 
in the house, as well as the use of mosquito control meas-
ures [insecticide-treated nets (ITNs), indoor residual spray-
ing (IRS)]. Finally, elevation was included as an ordinal 
variable with cut-offs defined using quartiles. The optimum 
model was determined using a likelihood ratio test compar-
ing the saturated to the reduced model.
Results
In total, 3566 people were sampled from 46 EAs with 
a mean of 78 (range 70–96) people sampled per EA 
(Table 1). Forty per cent (95 % CI 38.3–41.8, range 27.5–
54.4) of the population sampled were ≥20  years of age, 
whilst a low proportion of samples came from those aged 
15–20 years (7.4 %, 95 % CI 6.5–8.5 %, range 0–27.1 %). 
56.3 % (95 % CI 54.7–57.9, range 47.3–68.0) were female. 
Use of bed nets was the most common form of malaria 
Table 1 Demographic data of all surveyed households
Data includes the 95 % CI and range of values per cluster
N = 3566 Value 95 % CI Cluster range
Mean sampled per cluster 78 – 70–96
Median age (years) 13 – 9–22
Population sampled per age group (%)
 <5 22.5 21.2–23.9 12.5–31.2
 5–9.9 17.4 16.1–18.7 7.8–27.6
 10–14.9 12.6 11.2–14.2 4.0–27.1
 15–19.9 7.4 6.5–8.5 0–27.1
 ≥20 40.0 38.3–41.8 27.5–54.4
Gender (% female) 56.3 54.7–57.9 47.3–68.0
Travelled outside EA in 3 months (%) 5.0 3.3–7.4 0–30.7
House has open eaves (%) 81.7 80.5–83.0 0–100
Socio-economic status (%)
 1 (low) 23.3 19.4–27.7 0–57.1
 2 19.2 16.0–22.9 0–56.9
 3 24.4 20.5–28.7 1.0–61.1
 4 13.7 11.3–16.6 0–40.7
 5 (high) 19.4 15.1–24.6 0–64.6
Mosquito control (%)
 Net only 29.7 24.9–35.0 0–76.9
 IRS only 9.6 7.4–12.3 0–38.5
 Both 30.6 25.1–36.7 0–85.5
 None 24.0 19.6–29.1 0–70.4
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control with 60.3 % (95 % CI 58.7–61.9, range 12.3–91.7) 
of the population reporting having slept under a net the 
previous night. 24.0 % (95 % CI 19.6–29.1, range 0–70.4) 
of the population reported that they did not use bed nets 
nor had their house been sprayed in the past 12 months.
Malaria infection by RDT was low overall with a mean 
prevalence of 3.0 % (95 % CI 2.2–4.2 %) but this ranged 
by EA from 0 to 13.1 % (Table 2). The malaria prevalence 
by PCR was over twice that of RDT with 8.5 % (95 % CI 
7.0–10.4  %) being positive and 64.4  % (95  % CI 59.4–
69.4  %) of PCR infections were sub-patent (i.e., PCR 
positive but RDT negative). The parasite prevalence by 
PCR was also highly heterogeneous with clusters rang-
ing from 0 to 14.8 %. Exposure as assessed by antibody 
prevalence to malaria MSP antigen was 36.8  % (95  % 
CI 33.9–39.8  %) and varied by EA from 18.6 to 65.8  % 
(Table  2). Also, seropositivity in children  <5  years old 
varied from 0 to 44  % across EAs suggesting heteroge-
neity in recent exposure across the study area. Mean 
SCR was 0.038 (95 % CI 0.035–0.040). There was a sig-
nificant association between the rank of RDT and PCR 
prevalence at the EA level (Spearman’s p <0.001), but no 
association between SCR or seroprevalence and RDT 
(p = 0.185; p = 0.223) and PCR (p = 0.096; p = 0.114), 
respectively.
Children aged 5–10  years had the highest malaria 
prevalence by both RDT (6.1 %, 95 % CI 4.2–8.0 %) and 
PCR (13.1  %, 95  % CI 10.4–15.7  %) (Table  3). However, 
older age groups were found to have the highest propor-
tion of sub-patent infections; 78.1  % of PCR-confirmed 
infections in 15–20  year olds and 73.3  % of infections 
in those >20 years were sub-patent compared to 51.3 % 
in children <5 years (chi p = 0.015). Older children also 
reported the lowest bed net use; 55.6 % (95 % CI 51.0–
60.2 %) and 56.5 % (95 % CI 50.6–62.5 %) in the 10–15 
and 15–20 years age groups, respectively (Table 3).
Of the 46 EAs included in the survey, 15 had no RDT-
positive infections detected (Fig.  2a). In these clusters 
with no evidence of infection by RDT, the mean PCR 
prevalence was 5.0  % and this ranged between 0 and 
12.2  % (Fig.  2b). Similarly, despite no RDT-positive 
individuals present, 32.5  % of individuals were posi-
tive for MSP antibodies and this ranged from 18.6 to 
65.8  % (Fig.  3). In the 15 RDT-negative clusters, when 
seroprevalence estimates were restricted to those under 
5  years of age, a proxy for recent transmission, 14.3  % 
of children were seropositive and this ranged from 0 to 
43.7 %.
Variation according to EA altitude was observed for 
serological and parasitological outcomes. There was 
a large range in SCR across EAs (range: 0.013–0.128) 
and showed a non-significant negative trend with SCR 
decreasing by 0.0002 (95 % CI −0.0004 to 0.00001) with 
every 1 m increase in elevation. SCR was also highly vari-
able by EAs with a similar mean elevation (Fig. 4a). For 
one EA in particular, SCR was significantly higher than 
those of the same altitude range. However, when stratify-
ing the SCR by altitude band, those residing at an eleva-
tion between 1550 and 1665  m did show a significantly 
lower SCR compared to those residing at the lower eleva-
tions (Fig. 5a). Despite the overall RDT (Fig. 4b) and PCR 
(Fig. 4c) prevalence being low, no linear trend (increase 
Table 2 Overall estimates of  current malaria infection 
and exposure, as well as haemoglobin levels
Data given as means, corresponding 95 % CI and the range of values by cluster
Mean 95 % CI Cluster range
Proportion RDT positive 3.0 2.2–4.2 0–13.1
Proportion PCR positive 8.5 7.0–10.4 0–14.8
Proportion MSP-119 antibody posi-
tive
36.8 33.9–39.8 18.6–65.8
MSP-1 SCR 0.038 0.035–0.040 0.013–0.128
Mean Hb level (g/dl) 12.8 12.7–12.9 11.8–13.8
Proportion anaemic (<11 g/dl) 25.7 23.1–28.5 9.4–48.0
Table 3 Malaria outcomes and factors commonly associated with malaria stratified by age group
Data includes the corresponding 95 % CI
≤5 years 5.1–10 years 10.1–15 years 15.1–20 years >20 years
% 95 % CI % 95 % CI % 95 % CI % 95 % CI % 95 % CI
Malaria outcomes
 RDT Pos 4.1 2.7–5.4 6.1 4.2–8.0 4.0 2.2–5.8 2.6 1.0–4.5 1.0 0.4–1.4
 PCR Pos 7.8 5.9–9.7 13.1 10.4–15.7 10.4 7.5–13.2 10.6 6.9–14.4 6.0 4.8–7.2
 Sub-patent 51.3 39.7–63.0 61.5 51.3–71.7 61.8 48.6–75.1 78.1 63.0–93.3 73.3 64.7–81.9
Malaria factors
 Bed net use 60.7 57.3–64.1 61.1 57.3–65.0 55.6 51.0–60.2 56.5 50.6–62.5 61.9 59.4–64.4
 Travel 2.5 1.4–3.6 1.7 0.6–2.7 1.4 0.3–2.5 3.9 1.5–6.3 9.0 7.5–10.5
 Anaemic 41.6 38.2–45.0 22.9 19.6–26.3 13.9 10.7–17.1 16.8 12.3–21.4 23.3 21.1–25.5
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Fig. 2 Map of EAs by a RDT prevalence, b PCR prevalence
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of  ~0 per increase in 1  m of elevation; RDT, p  =  0.99; 
PCR, p = 0.32) was observed between EAs and elevation.
Next, seroprevalence curves were calculated based on 
the different reported mosquito control interventions. 
As would be expected, the group reporting having both 
received IRS and having slept under a bed net the previ-
ous night showed evidence of lower exposure compared 
to those reporting using a single intervention (Fig.  5b; 
data shown in Additional file 1). Interestingly, the expo-
sure in groups having reported using a single mosquito 
control intervention, either bed nets or IRS, showed no 
difference compared to the group that reported using no 
malaria control interventions (Fig. 5b).
Factors associated with malaria infection by RDT and 
PCR, and malaria exposure, defined as MSP seropositiv-
ity, were also assessed. The unadjusted analysis for RDT 
positivity suggested that older age was associated with 
reduced odds of infection whereas reporting use of IRS 
and residing in a house with open eaves increased the 
odds of being RDT positive (Table 4). Next, an adjusted 
analysis for RDT positivity was conducted (Table  5). 
Children between 5 and 10 years of age showed the high-
est odds (AOR 1.81; 95  % CI 1.16–2.81; p  =  0.009) of 
being infected compared to those under 5  years, whilst 
adults over 20  years were the least likely to be infected 
(AOR 0.27; 95 % CI 0.12–0.62; p = 0.003). Also, residing 
in a house with open eaves was associated with five times 
the odds of RDT infection (AOR 5.05; 95 % CI 1.6–16.0; 
p = 0.007). Use of mosquito control was also associated 
with having a patent infection with only those report-
ing use of IRS only being significant (AOR 2.61; 95 % CI 
1.01–6.78; p = 0.48).
In the unadjusted analysis using PCR positivity as 
the response variable, results were similar to those of 
RDT positivity. There were increased odds of infection 
in older children and in those residing in households 
reporting use of IRS only, whereas females were less 
likely to be infected (Table  4). In the adjusted analysis, 
PCR infections were greater in children aged 5–10 years 
compared to children <5 years (AOR 1.73; 95 % CI 1.22–
2.45). Wealthy households also exhibited lower odds 
of PCR infection compared to the poorest households 
although not all SES categories were statistically sig-
nificant (Table 5). Finally, there was borderline evidence 
(p = 0.051) to suggest that reporting use of both IRS and 
bed nets had greater odds of PCR infection than those 
using no interventions (AOR 1.67; 95  % CI 1.00–2.79). 
Those who reported using only IRS had over twice the 
odds of being PCR positive (AOR 2.13; 95  % CI 1.21–
3.75) compared to those with no vector control.
As expected for antibodies to P. falciparum MSP-
119, age was significantly associated with seropositivity 
Fig. 3 Map of EAs by seroprevalence
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(Table  4). As seen in Fig.  5a, a significant difference in 
seropositivity was observed only between EAs at the 
highest altitude compared to the lowest (OR 0.68, 95  % 
CI 0.52–0.77). Females also had increased odds of being 
seropositive (OR 1.41, 95 % CI 1.21–1.64). In the adjusted 
analysis those greater than 20  years had 8.18 times the 
odds of being seropositive compared to children under 
five (95 % CI 6.51–10.27; p < 0.001). Also, being anaemic 
was associated with increased odds of being seropositive 
(AOR 1.26; 95 % CI 1.02–1.56; p = 0.034). Both elevation 
and SES were associated with decreased odds of seropos-
itivity (Table 5). Those residing at the highest altitude had 
35 % reduction in odds of being seropositive (AOR 0.63; 
95 % CI 0.46–0.86; p = 0.005) compared to those living 
in the lowest elevation band. Similarly, those in the high-
est SES quintile had an AOR of 0.60 (95 % CI 0.52–0.92; 
p = 0.013) compared to the poorest quintile.
Discussion
In many areas, as malaria control interventions are scaled 
up, transmission is being reduced, resulting in an epide-
miological transition with changes in disease burden [1]. 
Factors associated with these transitions are likely multi-
faceted and due partly to both curative (increased availa-
bility and use of RDT and artemisinin-based combination 
therapy) and preventative measures (increased coverage 
of ITNs and IRS) [29–31]. As transmission decreases, 
surveys such as this one conducted in the western Ken-
yan highlands are important to understand the current 
local malaria epidemiology, describe the heterogeneity 
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of transmission and identify areas where transmission 
persists to allow better targeting of control interven-
tions. In this cross-sectional survey, three different but 
complimentary tools to assess malaria transmission 
were assessed: RDTs to determine those P. falciparum 
infections that would be targeted for treatment, PCR to 
identify current infections including those of low level 
parasitaemia and serology to describe historic exposure. 
The results here describe a large range in malaria expo-
sure within this area of nominally low transmission and 
that the more sensitive diagnostics, using PCR to detect 
parasite DNA and ELISA to detect antibodies to malaria, 
provide added value in terms of understanding the epi-
demiology in this setting and determining risk factors for 
malaria.
RDTs are useful in a clinical setting and can provide a 
crude metric for malaria prevalence. However, not unex-
pectedly, in this study a large proportion of the infections 
that were detected using the more sensitive PCR metric 
were missed by RDT. The presence of a large reservoir of 
sub-patent infections is common in low transmission set-
tings where parasite densities tend to be below the detec-
tion threshold of RDTs or microscopy [10]. Therefore, the 
more sensitive PCR metric provides an accurate estimate 
of the parasite reservoir in the community, the identifica-
tion of which is essential when considering malaria elimi-
nation [32]. The expense of the equipment and reagents 
and time taken to conduct current versions of molecular 
assays limit use as a routine diagnostic test [33], however 
these tools can identify which sections of the population 
harbour sub-patent infections and therefore could be tar-
geted for community-level control. For example, in this 
study the highest levels of sub-patent infection were in 
those over the age of 15 years.
Seroprevalence to the P. falciparum MSP antigen pro-
vided insight into malaria exposure levels in the study 
area. SCR has been associated with the entomologi-
cal inoculation rate (EIR), which provides a measure of 
transmission intensity [23]. The wide range of SCR as 
well as the range of seroprevalence in children <5 years 
Table 4 Univariable logistic regression analysis of factors associated with infection and exposure to Plasmodium falcipa-
rum
RDT PCR MSP
OR 95 % CI P value OR 95 % CI P value OR 95 % CI P value
Age group in years
 ≤5 1 – – 1 – – 1 – –
 5.1–10 1.5 0.98–2.4 0.058 1.78 1.2–2.4 0.001 1.48 1.11–1.97 <0.001
 10.1–15 0.97 0.57–1.65 0.91 1.37 0.91–2.04 0.125 2.77 2.1–3.68 <0.001
 15.1–20 0.63 0.27–1.47 0.28 1.41 0.79–2.51 0.24 4.69 3.51–6.27 <0.001
 >20 0.21 0.094–0.5 0.0001 0.75 0.51–1.1 0.141 7.56 5.97–9.58 <0.001
Sex (female) 0.88 0.60–1.29 0.505 0.74 0.58–0.95 0.021 1.41 1.21–1.64 <0.001
Anaemia (<11 g/dl) 2.7 1.75–4.25 0.0001 1.03 0.77–1.3 0.82 0.99 0.81–1.22 0.95
Socio-economic status (SES) score
 1 (low) 1 – – 1 – – 1 – –
 2 0.64 0.31–1.31 0.22 0.70 0.44–1.10 0.11 1.04 0.77–1.41 0.78
 3 0.65 0.33–1.25 0.19 0.91 0.56–1.5 0.71 0.80 0.63–1.02 0.072
 4 0.30 0.11–0.77 0.014 0.63 0.39–1.05 0.075 0.87 0.64–1.19 0.37
 5 (high) 0.45 0.21–0.93 0.033 0.84 0.55–1.27 0.407 0.81 0.62–1.07 0.13
Open eaves 6.04 1.8–20.1 0.004 1.2 0.9–1.6 0.19 0.88 0.62–1.2 0.5
Travel 0.18 0.028–1.13 0.066 0.58 0.24–1.40 0.218 1.34 0.99–1.83 0.059
Mosquito control
 None 1 – – 1 – – 1 – –
 Net only 0.95 0.45–1.97 0.88 1.19 0.81–1.77 0.363 1.04 0.77–1.41 0.80
 IRS only 2.5 1.01–6.15 0.05 2.01 1.13–3.56 0.02 1.13 0.81–1.59 0.46
 Both 1.13 0.50–2.57 0.76 1.33 0.87–2.04 0.18 0.79 0.59–1.05 0.106
Elevation (m)
 1430–1494 1 – – 1 – – 1 – –
 1495–1510 0.65 0.27–1.57 0.332 0.80 0.48–1.34 0.389 1.02 0.76–1.35 0.905
 1511–1529 0.83 0.44–1.58 0.571 1.24 0.72–2.13 0.419 0.95 0.70–1.29 0.749
 1530–1685 0.68 0.31–1.46 0.314 1.11 0.64–1.92 0.714 0.68 0.52–0.77 <0.001
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of age suggests that malaria exposure is highly variable 
in this area. As a measure that integrates exposure over 
time and reflects cumulative exposure rather than a sin-
gle current infection, serology can provide a more robust 
picture of the malaria transmission dynamics in an area. 
In this setting, in the EAs with no evidence of infections 
by RDT, serological and molecular tools enabled a more 
complete understanding of the ongoing transmission and 
allowed for an examination of risk factors. Serological 
outcomes can supplement metrics of current infection 
and be used to identify risk factors where transmission is 
low [34, 35].
In this population, consistent with other findings, 
age and wealth indicators were both associated with 
malaria infection by all metrics [36]. Children between 
5 and 10 years of age were more likely to be positive by 
both RDT and PCR compared to children under 5 years 
of age, whilst those over 20  years had reduced odds of 
RDT-confirmed infection. Those of higher SES were less 
likely to be infected with or show historical exposure 
to malaria. The presence of open eaves on households 
was also associated with being RDT positive, as would 
be expected due to increased house entry of the vec-
tor [37, 38]. House screening has been shown to reduce 
mosquito entry and reduce the odds of malaria infection 
[39–41].
Interestingly, altitude of residence of survey partici-
pants was not associated with either measure of current 
infection in the adjusted analysis and only with malaria 
exposure, determined by serology, at the highest alti-
tudes. This lack of association may be due to the low RDT 
and PCR prevalence in this population or due to the pre-
selected narrow altitude range. However, this suggests 
that the association with altitude and current infection 
may be more useful at a larger spatial scale [42] or that 
in this setting, measures of current infection may be less 
stable on such a short time scale but is consistent with 
altitude over longer time periods. Also, recent travel 
was not associated with any malaria metric even though 
travel is consistently seen as a risk factor for malaria 
[43]. However, travel, as a risk factor for malaria, will be 
dependent on who is travelling and their destination in 
terms of changes in risk. Previous studies have shown 
those with higher SES are more likely to travel and may 
Table 5 Multivariate logistic regression analysis of factors associated with infection and exposure to Plasmodium falcipa-
rum
RDT PCR MSP
AOR 95 % CI P value AOR 95 % CI P value AOR 95 % CI P value
Age group in years
 ≤5 1 – – 1 – – 1 – –
 5.1–10 1.81 1.17–2.81 0.009 1.73 1.22–2.45 0.003 1.57 1.17–2.11 0.003
 10.1–15 1.45 0.83–2.51 0.182 1.48 0.99–2.19 0.052 2.95 2.24–3.89 <0.001
 15.1–20 0.86 0.37–2.02 0.726 1.28 0.68–2.42 0.438 5.11 3.85–6.79 <0.001
 >20 0.27 0.12–0.62 0.003 0.77 0.52–1.13 0.180 8.18 6.51–10.27 <0.001
Anaemic (<11 g/dl) 2.91 1.88–4.53 <0.001 1.26 1.02–1.56 0.034
Elevation (m)
 1430–1494 1.0 – –
 1495–1510 1.0 0.72–1.38 0.995
 1511–1529 0.94 0.65–1.35 0.724
 1530–1685 0.63 0.46–0.86 0.005
Socio-economic status (SES) score
 1 (low) 1 – – 1 – – 1 – –
 2 0.53 0.20–1.46 0.217 0.57 0.35–0.94 0.030 1.07 0.77–1.50 0.674
 3 0.57 0.23–1.42 0.223 0.78 0.44–1.38 0.385 0.80 0.62–1.03 0.081
 4 0.30 0.10–0.93 0.038 0.58 0.33–1.02 0.059 0.83 0.59–1.17 0.290
 5 (high) 0.64 0.26–1.59 0.326 0.74 0.44–1.22 0.232 0.69 0.52–0.92 0.013
Open eaves 5.05 1.60–16.0 0.007
Mosquito control
 None 1 – – 1 – –
 Net only 1.40 0.49–4.01 0.516 1.54 0.98–2.43 0.060
 IRS only 2.61 1.01–6.78 0.048 2.13 1.21–3.75 0.010
 Both 1.49 0.52–4.29 0.446 1.67 1.00–2.79 0.051
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have a lower overall risk of malaria infection through 
increased knowledge and use of protective measures. 
Also, it has been found that the majority of people in this 
population travel to Nairobi, the capital city, which has 
a low or negligible risk of malaria compared to the Kisii 
and Rachuonyo [44]. Therefore, the lack of association 
with travel is not surprising.
Regression analyses suggested that those who had 
received IRS in the past 12  months had an increased 
risk of being malaria positive at the time of the survey. 
Although this is at first counter-intuitive, this finding 
is likely confounded by the fact that areas with higher 
perceived risk tend to be the ones more like to be tar-
geted and receptive to the use of mosquito control [45]. 
In 2009 areas considered to be of higher risk in Kenya 
were targeted for the IRS campaign. Also, that year the 
IRS campaign was conducted after onset of the rains; at 
the time of the survey the current campaign was near-
ing completion. The RDT and PCR results may there-
fore have not measured any benefit of the campaign that 
year.
It was observed that those who reported using both 
ITN and IRS resided in a cluster with a significantly lower 
SCR than those using just a single intervention. This sug-
gests that combining interventions may be more efficient 
at reducing exposure and driving transmission to even 
lower levels, as demonstrated in modelling studies [46–
48]. Data from studies in Bioko Island, lowland Kenya 
and Tanzania indicated combining ITN and IRS resulted 
in lower prevalence and incidence of malaria than those 
who received only nets [19, 49–51]. However, other tri-
als and observational studies in Africa indicate little or 
no added benefit of combining interventions [52–55]. As 
each intervention is scaled up within Kenya and across 
the continent, it is increasingly likely that people will be 
protected by both ITN and IRS [56] and therefore the 
synergistic effect of the combined intervention coverage 
should be further explored [54].
One limitation of the serology component of this 
study was the use of only one antigen (which was all 
that was available at the time) to assess anti-malarial 
antibody responses. Increasing the number of antigens 
would most likely lead to marginal increases in the 
overall seroprevalence estimates due to heterogene-
ous immunity in the population. However, whilst this 
means that the serological outcomes presented here 
can be assumed to be underestimates, responses to 
non-variant antigens such as MSP-119 with a compara-
tively long antibody half-life [57] should be considered 
reasonably robust [58]. Furthermore, it is acknowl-
edged that the small sample sizes within each clus-
ter affects the precision of the estimated cluster-level 
SCR and are highlighted in the width of the reported 
confidence intervals. Calculations of SCR would be 
more robust with standardized age ranges per cluster 
but as the household survey was designed and powered 
to estimate parasite rate, and given that the sampling 
framework included all ages and the SRR was fixed, the 
bias is minimized [24].
In this study, EAs were sampled from two districts: 
Kisii is classified as having low and epidemic-prone 
malaria transmission whereas Rachuonyo has low and 
stable transmission. However, analysis of malaria bur-
den determined by all metrics at the EA level showed 
no clear differences, with those with the highest bur-
den being equally in both districts. The cluster with the 
highest SCR was in fact located in Kisii, the district with 
lower overall reported levels of malaria burden (although 
the low sample sizes used to estimate SCR on the EA 
level are acknowledged). This suggests that allocating 
resources at the district level may not be ideal; pockets 
of high burden within the overall low transmission area 
would be missed and may seed transmission to neigh-
bouring areas [59]. Although it is logistically more dif-
ficult to deploy malaria control interventions at a more 
refined spatial scale, such efforts may prove to be more 
efficient as interventions could be more precisely tar-
geted and prove to be more cost-effective than blanket 
treatment. Therefore, strong health systems and surveil-
lance based on sensitive diagnostic tools, as well as the 
capacity to analyse the data collected, will be necessary 
for informed decisions to be made at a time scale that is 
relevant for malaria control.
Conclusion
Ultimately, in the highlands in western Kenya, malaria 
transmission is generally low, but highly heterogeneous 
and difficult to measure accurately using routine diagnos-
tic tools. This study found a large range in malaria bur-
den at the EA level and a large population of sub-patent 
infections. This suggests that for malaria surveillance and 
monitoring, more sensitive metrics such as molecular or 
serological methods may complement current diagnos-
tic tools in order to accurately assess malaria burden in 
the population, determine reservoirs of infection, iden-
tify risk factors and, therefore, better target appropriate 
interventions.
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